RFK Jr. in Brazilian Interview: “Nicotine pouches are probably the safest way to consume nicotine”
30th Jul 2025
In a widely noted interview with Brazilian media, U.S. Health Secretary Robert F. Kennedy Jr. voiced sharp criticism of the explosive rise of Chinese vapes—while clearly stating that nicotine pouches are the safest way to consume nicotine.
Chinese vapes targeting children: “We are very worried”
When asked about the surge of Chinese vapes—often marketed with colorful designs and candy-like flavors—RFK Jr. was clear:
“They are directed towards children. They have these bright colours and candy-like flavours. We are very worried about these vapes.”
He emphasized that the U.S. is currently conducting a nationwide crackdown on such products:
“We are now doing a crackdown on them, a nationwide crack down. We’re being very aggressive.”
A differentiated view: “Fast-tracking approval for serious alternatives”
At the same time, Kennedy pointed out that not all vapes are the problem—and that U.S. authorities are working to fast-track approval for products that are not aimed at children or designed to attract them through flavors or playful branding.
It’s about distinguishing between harmful and less harmful nicotine products—a view that is gaining ground in more and more countries.
“Nicotine pouches are probably the safest way”
Perhaps most striking were RFK Jr.’s comments about nicotine itself:
“Nicotine itself does not cause cancer. Nicotine is of course clearly addictive but it is not carcinogenic.”
He also outlined a clear risk hierarchy among nicotine products:
“Nicotine pouches are probably the safest way to consume nicotine, with vapes being second. But the thing we really want to get away from are cigarettes.”
A more nuanced approach to public health
Kennedy’s position reflects a growing recognition that not all nicotine products are equally harmful. The real enemy, according to him, remains the cigarette—which he says costs the U.S. healthcare system $640 billion a year.
This perspective puts pressure on lawmakers and public health advocates alike to keep the facts straight in what is often a highly polarized debate on nicotine.
Europe needs more courage—and more science
As the FDA now acts with clarity, science, and determination, an important question arises:
When will Europe follow?
European health ministers, regulatory authorities, and legislators must find inspiration in the courage now being demonstrated across the Atlantic. What’s needed is the same risk-proportionate and pragmatic approach here in Europe—especially if we are serious about saving more lives.
